Carbamic Acid

Carbamic Acid

SCHEMBL1983191

NC(=O)O.O=C(CBr)c1ccc(Br)cc1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 11/20 0.83
PTPN1 P18031 5/20 0.59
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
OGG1 O15527 1/20 0.50
HAO1 Q9UJM8 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70930 0.91 GSK3B (1.00) GSK3BPTPN1HDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL9064086 0.89 GSK3B (0.95) GSK3BPTPN1HDAC3HDAC4HDAC1
SCHEMBL973263 0.85 GSK3B (0.87) GSK3BPTPN1HDAC3HDAC4HDAC1
SCHEMBL205280 0.82 GSK3B (0.80) GSK3BPTPN1HDAC3HDAC4HDAC1
SCHEMBL3379031 0.80 GSK3B (0.64) GSK3BPTPN1CA2
SCHEMBL8260473 0.80 GSK3B (0.77) GSK3BPTPN1HDAC3HDAC4HDAC1
Acetonitrile SCHEMBL27909938 0.80 GSK3B (0.77) GSK3BPTPN1HDAC3HDAC4HDAC1
SCHEMBL247615 0.78 GSK3B (0.70) GSK3BPTPN1CA1CA2
SCHEMBL11405057 0.77 GSK3B (0.59) GSK3BPTPN1
SCHEMBL11060497 0.77 OGG1 (0.63) GSK3BHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337781-A2 ANTI-VIRAL COMPOUNDS TO TREAT HCV INFECTION Abbott Laboratories (US) 2011-06-29 EP disclosed
WO-2010144646-A2 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2010-12-16 WO disclosed